{"document_type": "article", "byline": {"contributor": "", "person": [{"role": "reported", "firstname": "Denise", "organization": "", "rank": 1, "lastname": "GRADY"}], "original": "By DENISE GRADY"}, "news_desk": "Science", "slideshow_credits": null, "abstract": null, "multimedia": [{"type": "image", "url": "images/2016/12/21/science/28CANCER2/28CANCER2-thumbWide.jpg", "legacy": {"wide": "images/2016/12/21/science/28CANCER2/28CANCER2-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "width": 190, "subtype": "wide", "height": 126}, {"type": "image", "url": "images/2016/12/21/science/28CANCER2/28CANCER2-articleLarge.jpg", "legacy": {"xlarge": "images/2016/12/21/science/28CANCER2/28CANCER2-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "400"}, "width": 600, "subtype": "xlarge", "height": 400}, {"type": "image", "url": "images/2016/12/21/science/28CANCER2/28CANCER2-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/12/21/science/28CANCER2/28CANCER2-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "width": 75, "subtype": "thumbnail", "height": 75}], "headline": {"print_headline": "Minorities Face Extra Hurdles in Cancer Trials", "main": "In Cancer Trials, Minorities Face Extra Hurdles"}, "print_page": "1", "keywords": [{"value": "Cancer", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Clinical Trials", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Minorities", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Blacks", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "5", "name": "subject"}], "snippet": "As immunotherapy research takes off, the patients getting the treatment have been overwhelmingly white. Researchers know this and say they are trying to correct it....", "source": "The New York Times", "lead_paragraph": "As immunotherapy research takes off, the patients getting the treatment have been overwhelmingly white. Researchers know this and say they are trying to correct it.", "word_count": "2250", "pub_date": "2016-12-23T10:01:27+0000", "subsection_name": null, "blog": [], "type_of_material": "News", "section_name": "Health", "web_url": "http://www.nytimes.com/2016/12/23/health/cancer-trials-immunotherapy.html", "_id": "585cf5fc95d0e03926077861"}